SEC Form 4 · accession 0001209191-18-034020
ImmunityBio, Inc. · IBRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steve Gorlin
Director
Period of report
May 24, 2018
Accepted (ET)
May 29, 2018 · 7:53 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001326110
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 24, 2018 | S | 303 | $3.96 | D | 409,600 | I | By spouse |
| Common Stock | May 25, 2018 | S | 3,400 | $3.97 | D | 406,200 | I | By spouse |
| Common Stock | May 25, 2018 | S | 200 | $3.98 | D | 406,000 | I | By spouse |
| Common Stock | May 29, 2018 | S | 1,500 | $3.89 | D | 404,500 | I | By spouse |
| Common Stock | May 29, 2018 | S | 500 | $3.90 | D | 404,000 | I | By spouse |
| Common Stock | May 29, 2018 | S | 100 | $3.895 | D | 403,900 | I | By spouse |
| Common Stock | holding | — | — | — | 246,280 | D |
Table II — derivative securities
No Table II lines on this filing.